再生医療の世界市場：治療法 (細胞療法、遺伝子療法)・製品 (自己細胞／同種異系細胞／無細胞)・用途・地域別の予測

当レポートでは、世界の再生医療の関連市場について分析し、製品の概要や全体的な市場構造、主な市場促進・抑制要因、治療法別・製品別・用途別・地域別の市場動向見通し (今後7年間分)、市場競争の概況、昨今の資本取引・戦略展開の動き、主要企業のプロファイルなどについて調査・推計しております。

第1章 再生医療：市場概況

第2章 エグゼクティブ・サマリー

第3章 市場環境

• 市場シェア分析
• 比較分析
• 製品の相互比較
• エンドユーザーのプロファイル
• 上位5社の財務分析

第4章 再生医療市場の影響要因

• 市場促進要因
• 市場抑制要因
• 市場機会
• 課題
• ポーターのファイブフォース分析

第5章 再生医療市場：戦略分析

• バリューチェーン分析
• 価格動向分析
• 市場機会の分析
• 製品／市場のライフサイクル分析
• サプライヤー・流通業者

第6章 再生医療市場：治療法別

• 細胞療法
• 遺伝子療法
• ティッシュエンジニアリング (組織工学)
• 免疫療法

第7章 再生医療市場：製品別

• 自己細胞製品
• 同種異系細胞製品
• 無細胞製品

第8章 再生医療市場：用途別

• 整形外科・筋骨格系脊椎
• 皮膚
• 心血管
• 中枢神経系 (CNS)
• 腫瘍
• 糖尿病
• その他

第9章 再生医療市場：地域別

• 欧州 (ドイツ、フランス、イタリア、スペイン、ロシア、英国など)
• アジア太平洋地域 (中国、日本、インド、韓国など)
• 北米 (米国、カナダ、メキシコ)
• 他の国々 (RoW) (ブラジルなど)

第10章 再生医療市場：市場変化の方向性

• 事業拡張
• 技術進歩
• 企業合併・買収 (M&A)、合弁事業
• 供給契約

第11章 企業プロファイル

第12章 付録

Regenerative medicines are capable of restoring the functionality of cells & tissues by treating a patient with laboratory grown cells and tissues. Regenerative medicines are used in a wide range of degenerative disorders such as dermatology, neurodegenerative diseases, cardiovascular and orthopaedic applications. Globally, development of efficient and advance technology in tissue and organ regeneration, growing funding from government and private organizations to support the development of regenerative medicines products, rise in the awareness among people regarding regenerative medicine, increasing government initiative across the globe, and growing aging population and healthcare expenditure are the prime growth drivers of global regenerative medicine market. In addition, Emergence of utilization of nanomaterial in wound care, drug delivery, and immunomodulation, increase in adoption of regenerative medicine for peripheral artery diseases, and emerging economies such as China, India and others, will create new opportunities for global regenerative medicine market. However, higher cost of the research and development, and complex government approval processes are the key restraints for global regenerative medicine market.

Geographically North America dominated global regenerative medicine market because of high medical reimbursement facilities, and technological advancement. Asia Pacific is projected to have fastest growth, owing to rapidly increasing aging population and per capita healthcare expenditure, rise in consumer awareness, higher focus on research in regenerative medicines especially in Japan, favourable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing nations such as China, and India in this region. Among all the application, orthopaedic & musculoskeletal spine segment has the highest market share in global regenerative medicine market due to higher prevalence of musculoskeletal cases and growing investments in orthopaedic research.

This report identifies the global regenerative medicine market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global regenerative medicine market.

This report segments global regenerative medicine market on the basis of therapy, product, application, and regional market as follows:

Regenerative Medicine Market, By Therapy: Cell Therapy, Gene Therapy, Tissue Engineering, and Immunotherapy

Regenerative Medicine Market, By Product: Autologous Cell-Based Products, Allogeneic Cell-Based Products, and Acellular Products

The report has focused study on regenerative medicine market by basis of application such as: Orthopedic & Musculoskeletal Spine, Dermatology, Cardiovascular, Central Nervous System, Oncology, Diabetes, and Others

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the regenerative medicine market. Some of the major companies' profiles in detail are as follows:

Japan Tissue Engineering Co., Ltd

Vertex Pharmaceuticals Incorporated

Cytori Therapeutics Inc.

Celgene Corporation

Acelity (KCI Licensing)

1. Regenerative Medicine Market - Market Overview

2. Executive Summary

3. Market Landscape

• 3.1. Market Share Analysis
• 3.2. Comparative Analysis
• 3.3. Product Benchmarking
• 3.4. End User Profiling
• 3.5. Top 5 Financials Analysis

4. Regenerative Medicine Market- Market Forces

• 4.1. Drivers
• 4.1.1. Development of efficient and advance technology in tissue and organ regeneration
• 4.1.2. Growing funding from government and private organizations to support the development of regenerative medicines products
• 4.2. Restraints
• 4.2.1. Higher cost of research and development
• 4.3. Opportunities
• 4.3.1. Emerging economies
• 4.4. Challenges
• 4.5. Porter's Five Forces Analysis
• 4.5.1. Bargaining Power of Suppliers
• 4.5.2. Bargaining Power of Buyers
• 4.5.3. Threat of New Entrants
• 4.5.4. Threat of Substitutes
• 4.5.5. Degree of Competition

5. Regenerative Medicine Market- Strategic Analysis

• 5.1. Value Chain Analysis
• 5.2. Pricing Analysis
• 5.3. Opportunities Analysis
• 5.4. Product/Market Life Cycle Analysis
• 5.5. Suppliers and Distributors

6. Regenerative Medicine Market, By Therapy

• 6.1. Cell Therapy
• 6.2. Gene Therapy
• 6.3. Tissue Engineering
• 6.4. Immunotherapy

7. Regenerative Medicine Market, By Product

• 7.1. Autologous Cell-Based Products
• 7.2. Allogeneic Cell-Based Products
• 7.3. Acellular Products

8. Regenerative Medicine Market, By Application

• 8.1. Orthopedic & Musculoskeletal Spine
• 8.2. Dermatology
• 8.3. Cardiovascular
• 8.4. Central Nervous System
• 8.5. Oncology
• 8.6. Diabetes
• 8.7. Others

9. Regenerative Medicine Market, By Geography

• 9.1. Europe
• 9.1.1. Germany
• 9.1.2. France
• 9.1.3. Italy
• 9.1.4. Spain
• 9.1.5. Russia
• 9.1.6. U.K.
• 9.1.7. Rest of Europe
• 9.2. Asia Pacific
• 9.2.1. China
• 9.2.2. India
• 9.2.3. Japan
• 9.2.4. South Korea
• 9.2.5. Rest of Asia-Pacific
• 9.3. North America
• 9.3.1. U.S.
• 9.3.2. Canada
• 9.3.3. Mexico
• 9.4. Rest of the World (RoW)
• 9.4.1. Brazil
• 9.4.2. Rest of RoW

10. Regenerative Medicine - Market Entropy

• 10.1. Expansion
• 10.2. Technological Developments
• 10.3. Merger & Acquisitions, and Joint Ventures
• 10.4. Supply- Contract

11. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

• 11.1. Japan Tissue Engineering Co., Ltd
• 11.2. Vertex Pharmaceuticals Incorporated
• 11.3. Cytori Therapeutics Inc.
• 11.4. Celgene Corporation
• 11.5. Acelity (KCI Licensing)
• 11.6. Nuvasive, Inc.
• 11.7. Organogenesis Inc.
• 11.8. Vericel Corporation
• 11.9. Cytori Therapeutics Inc.
• 11.10. Stemcells, Inc.

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

12. Appendix

• 12.1. Abbreviations
• 12.2. Sources
• 12.3. Research Methodology
• 12.4. Bibliography
• 12.5. Compilation of Expert Insights
• 12.6. Disclaimer